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Abstract
Overview—Substance use and substance use disorders are highly prevalent among youth under 
juvenile justice (JJ) supervision, and related to delinquency, psychopathology, social problems, 
risky sex and sexually transmitted infections, and health problems. However, numerous gaps exist 
in the identification of behavioral health (BH) problems and in the subsequent referral, initiation 
and retention in treatment for youth in community justice settings. This reflects both 
organizational and systems factors, including coordination between justice and BH agencies.
Correspondence to: Steven Belenko.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Clinical Trials Registration number – NCT02672150
HHS Public Access
Author manuscript
J Subst Abuse Treat. Author manuscript; available in PMC 2018 March 01.
Published in final edited form as:
J Subst Abuse Treat. 2017 March ; 74: 80–91. doi:10.1016/j.jsat.2016.12.012.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Methods and Results—This paper presents a new framework, the Juvenile Justice Behavioral 
Health Services Cascade (“Cascade”), for measuring unmet substance use treatment needs to 
illustrate how the cascade approach can be useful in understanding service delivery issues and 
identifying strategies to improve treatment engagement and outcomes for youth under community 
JJ supervision. We discuss the organizational and systems barriers for linking delinquent youth to 
BH services, and explain how the Cascade can help understand and address these barriers. We 
provide a detailed description of the sequential steps and measures of the Cascade, and then offer 
an example of its application from the Juvenile Justice – Translational Research on Interventions 
for Adolescents in the Legal System project (JJ-TRIALS), a multi-site research cooperative funded 
by the National Institute on Drug Abuse.
Conclusion—As illustrated with substance abuse treatment, the Cascade has potential for 
informing and guiding efforts to improve behavioral health service linkages for adolescent 
offenders, developing and testing interventions and policies to improve interagency and cross-
systems coordination, and informing the development of measures and interventions for improving 
the implementation of treatment in complex multisystem service settings.
Keywords
substance abuse treatment; juvenile justice; delinquent youth; barriers to treatment access; 
continuum of services; evidence-based practices
1. Introduction
The prevalence of substance use and substance use disorders (SUD) among adolescents 
under juvenile justice (JJ) supervision is much higher than for general community 
populations, and is related to delinquency, psychopathology, social problems, risky sex and 
sexually transmitted infections, and other health problems (Clark, 2004; Hicks, Iacono, & 
McGue, 2010). An estimated 70% of arrested juveniles have had prior drug involvement 
(Belenko & Logan, 2003), and 78% have recently used alcohol or drugs (Zhang, 2004). 
Adolescent substance use has serious negative consequences for adolescent development, 
school performance, and increases risk for progression to a SUD in both adolescence 
(Winters & Lee, 2008) and adulthood (Englund, Egeland, Oliva, & Collins, 2008; Stone, 
Becker, Huber, & Catalano, 2012; Swift, Coffee, Carlin, Degenhardt, & Patton, 2008). 
Arrested youth initiate substance use earlier than other adolescents, leading to more 
problematic substance use and higher recidivism (Henggeler, Clingempeel, Bronidon, & 
Pickrel, 2002; Kandel & Davies, 1992; Kandel & Yamaguchi, 2005). Wasserman and 
colleagues (2010) found that more than a third of a national sample of juvenile delinquents 
had SUDs, with rates increasing across justice system penetration.
The relationship between substance use and delinquency, however, is not straightforward. 
Not only do rates differ for specific groups of youth, but recommended treatment approaches 
also differ depending on their unique needs. For example, the relationship between alcohol 
use and delinquency is stronger among males and younger youth (Barnes, Welte, & 
Hoffman, 2002). Females comprise only 27% of the national JJ justice population (Scott & 
Dennis, 2016), yet have higher rates of anxiety and affective disorders (Wasserman, 
McReynolds, Ko, Katz, & Carpenter, 2005). Among adolescents in general, up to 90% of 
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those with a SUD meet criteria for one or more psychiatric disorders (Chan, Dennis, & 
Funk, 2008; Kandel et al., 1999). Similar trends are evidenced among JJ-involved youth 
(Wasserman et al., 2010), which further illustrates the need to provide appropriate treatment 
to reduce delinquency and increase functionality. Thus, it is critical that the JJ system 
address the treatment needs of juveniles with SUDs to promote both public safety and 
improve health outcomes. The capacity of the JJ system to do so remains problematic given 
the lack of coordination and integration of SUD and mental health services in most 
communities, a problem that plagues the ability to provide a continuum of care or to provide 
integrated services. It is well-recognized that adolescent treatment that addresses both 
substance abuse and mental health needs is more likely to be more effective than treatments 
that address only one disorder (see Robinson & Riggs, 2016; NIDA, 2014; Teplin et al., 
2005).
Problem identification and triage into appropriate services can be difficult to accomplish, 
especially in large systems serving diverse groups of youth and where staff must coordinate 
services across multiple agencies. Improving outcomes for justice-involved youth requires 
the identification of underlying behavioral health (BH) issues that may be contributing to the 
youth’s delinquency. It is imperative, however, that the system goes beyond simply 
identifying problems—youth must be referred to appropriate services and agencies from 
different service systems must collaborate and develop interagency strategies to ensure that 
youth actually receive these services as intended. Achieving this goal requires effort that 
crosses organizational boundaries and a systems-level view of how youth are being 
identified and served. These efforts can be facilitated by reliance on a unifying conceptual 
framework for illustrating, documenting, and understanding how justice-involved youth 
move across and between the multiple settings in which they receive services. The Juvenile 
Justice Behavioral Health Services Cascade framework (hereinafter referred to as the 
“Cascade”) presented in this paper provides an approach, informed by data, to tracking the 
aggregated movement of youth across these systems and providing a common metric for 
understanding and comparing diverse systems.
The Cascade framework described herein is not intended to capture all subtleties in the ways 
in which youth are linked to services, but rather is a first step toward conceptualizing the 
fundamental elements of a structured service continuum. Our emphasis is on demonstrating 
how the Cascade model can be used to address unmet substance abuse treatment needs; 
however, the framework also has broader uses for other BH issues. In its application with 
SUDs, we argue that all youth who enter the JJ system should be screened for substance use 
and other BH problems. This screening should be used to determine whether youth are 
assessed with a more comprehensive and validated assessment protocol and whether they are 
referred to other services, such as evidence-based prevention or treatment interventions 
(Models for Change, 2007; NIDA, 2014). The assessment results should then trigger a case 
plan and specific treatment recommendation (Wasserman, Jensen, Ko, Trupin, & Cocozza, 
2003). Once such a plan is developed, the youth should be referred to an appropriate 
treatment provider (American Society of Addiction Medicine, 2013), receive a clinical 
assessment, initiate treatment, and remain engaged in evidence-based treatment for a 
sufficient length of time to improve outcomes.
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Herein, we describe an optimal continuum of services from screening through treatment 
engagement, discuss organizational and systems barriers for linking delinquent youth to 
SUD services, provide a detailed description of the sequential Cascade steps and measures, 
and offer an example of its application from the Juvenile Justice - Translational Research on 
Interventions for Adolescents in the Legal System (JJ-TRIALS) multi-site research 
cooperative, funded by the National Institute on Drug Abuse (NIDA). The Cascade has other 
potential applications beyond its use in a research environment, such as providing juvenile 
and treatment agencies with a template for assessing progress in service delivery. This paper 
focuses on the research application but the discussion also highlights the other potential uses 
of the Cascade framework.
1.1. The optimal continuum of services
The JJ system clearly has responsibility for addressing youth health needs in secure facilities 
(U.S. Department of Justice, 2016). However, we focus on community supervision because 
it is the most common JJ supervision type for delinquent youth (Furdella & Puzzanchera, 
2015), and because the challenges of identifying SUD problems and referral/linkage to 
treatment are much greater than within secure institutional settings (Taxman & Belenko, 
2012, Wasserman et al., 2003). For youth under community supervision there is increasing 
acceptance that identification of substance use service needs and community services 
linkage is an effective strategy for reducing recidivism (Evans-Cuellar, Wasserman, 
McReynolds, Ko, & Katz, 2006; Hoeve, McReynolds, & Wasserman, 2013). But much 
variation exists across jurisdictions in this continuum of substance use services. Some 
jurisdictions conduct comprehensive assessment and provide treatment services directly, 
while most rely on community providers. In most JJ systems, youth with SUDs who require 
treatment will likely be referred to external providers for one or more services (Scott & 
Dennis, 2015; Steadman, 1992). A survey of nationally representative sample of counties 
estimated that of 4,252 primary providers of substance use and mental health services for 
youth under community justice supervision, 2,823 (66%) provided both, 778 (18%) provided 
only mental health treatment services and 651(15%) provided only substance use treatment 
services (Scott & Dennis, 2016). While the growing number of service providers that 
provide both substance abuse and mental health services is encouraging, the service delivery 
sequence often breaks down (even at the initial step of screening), and deteriorates further as 
youth transition from JJ to community provider agencies for treatment.
Even when cross-system linkages are in place, youth in the JJ system still are less likely to 
receive evidence-based practices (EBPs; Belenko & Dembo, 2003). National data on 
specialty adolescent SUD treatment programs have shown that the average program had only 
adopted half of the indicators of high-quality SUD care and EBPs (Knudsen, 2009). Even 
for youth treated in secure facilities (where service provision is presumably achieved more 
smoothly), access to EBPs is limited (Burney-Nissen, Butts, Merrigan, & Kraft, 2006; Office 
of Applied Studies, 2000). Ultimately, the effectiveness of the Cascade depends on agencies’ 
ability to provide evidence-based services, and to keep young persons engaged in services 
long enough to benefit from them.
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1.2. Challenges in addressing behavioral health needs
Organizational and systems factors affect the ability of agencies to address BH needs. First, 
the different missions of the JJ and BH treatment systems lead to different priorities and 
goals. The primary focus of community JJ system agencies is on public safety, social 
control, and efficient case processing, with identifying or addressing BH service needs a 
secondary goal (Belenko & Dembo, 2003; Taxman, Henderson, Young, & Farrell, 2014; 
Wasserman et al., 2009). By contrast, BH systems are interested in identifying and treating 
SUD and/or mental health issues, regardless of a youth’s delinquent behavior.
Second, as with other complex service systems, there is often problematic or inconsistent 
collaboration and information exchange across JJ and BH service sectors (Aarons, Hurlburt, 
& Horwitz, 2011; McGovern, Lambert-Harris, Gotham, Claus, & Xie, 2014; Proctor et al., 
2009). Interorganizational linkages between community JJ agencies and community-based 
assessment and treatment providers are rarely smooth (Belenko, Sprott, & Petersen, 2004; 
De Leon & Jainchill, 2012; Young, Dembo, & Henderson, 2007). Reasons include lack of 
shared mission across systems, competing priorities for JJ staff, lack of an incentive 
structure to promote JJ staff interest in identifying service needs and making referrals, and 
lack of information exchange across systems (Snyder & Sickmund, 2006; Taxman & 
Belenko, 2012).
Given varying goals, missions, and operations, JJ and BH organizations must collaborate to 
ensure that youth’s needs are being met (Henderson & Taxman, 2009; Roman, Butts, & 
Roman, 2011). Examples range from sharing physical space, manuals, forms, or staff, to 
joint training and operational procedures, to co-location of services. Effective collaboration 
can facilitate and help monitor transitions from one system to another, facilitate use of 
assessment information to match youth to appropriate programs, and promote active case 
management (e.g., making or managing appointments, providing transportation) to improve 
treatment engagement and retention. In systems of care where services are more likely to be 
coordinated, EBPs are also more likely to be adopted (Lehman, Fletcher, Wexler, & 
Melnick, 2009; Taxman & Bouffard, 2000), a broader range of programs and services are 
offered (Taxman, 1998), and the operational practice tends to mimic integrated care (Drake, 
2011).
Third, JJ staff members are seldom well-trained on SUD and other BH issues (Boesky, 2001; 
Grisso, Barnum, Fletcher, Cauffman, & Peuschold, 2001; McLellan & Meyers, 2004), and 
may not recognize the importance of good assessment, case planning, and referral to 
adequate services that address a youth’s specific needs. They are also not sufficiently 
familiar with programming to know when youth are receiving integrated care for SUD and 
mental health or treatment for merely one disorder. Legal and procedural protections can 
also present a barrier to sharing information where providers face health care system 
restrictions (e.g., HIPAA restrictions on information exchange).
The complexity of the process means that it is difficult for service providers and researchers 
alike to organize, collect, and analyze data across the Cascade stages, limiting the ability to 
identify system gaps and problems at various key points. An organizing framework and 
associated tools can help clarify the process, detect data and service needs, and identify 
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cross-systems linkage points (including potential opportunities for making cross-systems 
referrals and sharing information). Such a framework can help agencies and policy makers 
understand how the process is working, determine where improvements are needed, and 
inform development and testing of interventions to improve linked service delivery at each 
phase.
2. The Juvenile Justice Behavioral Health Services Cascade
The Juvenile Justice Behavioral Health Services Cascade was developed by NIDA’s JJ-
TRIALS team. JJ-TRIALS is a research cooperative (including six research centers, a 
coordinating center, and NIDA) that is experimentally testing a multi-site implementation 
intervention protocol to (1) reduce unmet substance use treatment needs among delinquent 
youth under community supervision, and (2) increase use of EBPs. The overall study design 
is described in detail elsewhere (Knight et al., 2016). In brief, the study involves delivering a 
multi-component training, and technical assistance intervention to 35 JJ agencies (primarily 
probation departments) and their BH partners that provide substance use treatment services. 
Training and technical assistance focuses primarily on helping agencies identify and select 
goals to reduce unmet substance use services needs among the youth they serve. Half of the 
sites are randomly selected to receive additional support through external facilitation of a 
local change team tasked with pursuing the selected goals.
The Cascade is a unifying conceptual framework designed to help identify research 
questions, hypotheses, potential interventions, and data collection needs, and to serve as a 
platform for guiding study sites to the selection of goals to reduce unmet service needs. As 
youth with substance use service needs move through the JJ system, there are multiple 
opportunities to engage youth in treatment services. For youth under community JJ 
supervision, the process is complicated by the fact that they are commonly screened in a 
community JJ setting, but typically receive treatment services in community specialty care 
sectors, requiring them to navigate multiple systems, and making a focus on cross-system 
linkage and information sharing essential for effective care. It is a complex, multi-stage and 
multi-system process. The Cascade was designed to help JJ and BH staff understand this 
process and track changes in youth services over time.
2.1. The HIV Care Cascade
The concept of sequential stages of SU treatment services from problem identification 
through treatment engagement has existed for many years (Scott & Dennis, 2009, 2011), but 
the structure and visual representation of the Cascade was particularly informed by the HIV 
care cascade, which has emerged in recent years as a widely used framework for both 
depicting gaps in HIV surveillance and treatment, and for estimating the impact of 
interventions to increase engagement in treatment and viral suppression to undetectable 
levels. The HIV cascade has been used to describe the HIV epidemic at local, national, and 
international levels, with successive bars illustrating the numbers of individuals subsequently 
diagnosed, linked to care, retained in care, receiving antiretroviral therapy, and achieving 
viral suppression (Gardner, McLees, Steiner, Del Rio, & Burman, 2011; Greenberg et al., 
2009; MacCarthy et al., 2015). It provides a quantitative visual depiction of the various 
Belenko et al. Page 6
J Subst Abuse Treat. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
service and medical stages needed to maximize HIV medical care from initial diagnosis 
through viral suppression (the ultimate public health goal).
The HIV care cascade has predominantly used outcome-focused population-level estimates 
to illustrate and isolate where individuals are “lost” in the care continuum (Mugavero, 
Amico, Horn, & Thompson, 2013). The HIV cascade has been embraced by the United 
States HIV/AIDS Strategy and the World Health Organization (White House Office of 
National AIDS Policy, 2010). The rapidity with which the HIV cascade has been adopted by 
HIV providers, researchers, and policy-makers speaks to its relative simplicity, visual power, 
and applicability to examining a number of aspects of HIV care. We recognize that 
significant differences exist between HIV and BH care systems, such as (1) differences in 
professional training and salaries; (2) more streamlined referrals within the medical system 
for HIV care, between providers with similar goals, and (3) clearer and more standardized 
treatment protocols in the HIV care system. However, the cascade concept and its visual 
depiction of data provide a common vocabulary that can facilitate efforts to achieve public 
health goals in different populations and settings.
2.2. Components of the Juvenile Justice BH Services Cascade
The Cascade (Figure 1) comprises six distinct interrelated activities that are essential for 
identifying substance use problems and triaging youth into appropriate clinical services. 
These include screening, assessment, identification of need (a discrete activity because 
screening and assessment results must be reviewed before a determination of need is made), 
referral to treatment, initiation, engagement, and continuing care. Implicit in the design of 
the Cascade is the idea that as youth transition across these service systems, communication 
and coordination is required between the justice system and the treatment providers. The 
Cascade focuses on SUD-related services. While it is recognized that a focus on integrated 
BH services (substance abuse and mental health) is desirable, the Cascade was initially 
created as a tool to identify utilization of various services which did not differentiate 
whether the treatment involved integrated care.
As indicated previously, many JJ agencies rely on independent community agencies to 
provide services along the Cascade. However, transition points, as well as location and 
purveyor, vary by jurisdiction. Bars on the left in Figure 1 (depicted in red) indicate services 
that would ideally occur within JJ settings (i.e., screening), in order to reach as many youth 
as possible. Indeed, screening is administered by JJ agencies in most JJ-TRIALS sites. Bars 
in the middle (depicted in purple) indicate a transition or “hand-off” from one agency to 
another (i.e., JJ referral to a provider for treatment), presumably after decisions have been 
made with regard to needed services. Bars on the right (depicted in blue) indicate 
engagement in treatment services. While some JJ agencies do provide services directly, the 
majority do not (Scott & Dennis, 2016). It is important to note that transitions can occur at 
nearly every point in the Cascade. JJ referral to treatment providers for assessment and 
identification of need is indicated by striped purple bars. Although not depicted, transitions 
can also occur between providers as youth engage in a continuum of care (transitioning to 
higher or lower levels of care; ASAM, 2013).
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2.2.1. Screening and assessment—Over the past two decades, greater focus has been 
placed on promoting BH screening in the JJ system, with recommendations for specific 
instruments. However, little attention has been paid to the entire process that should occur 
within a screening protocol and the sequence of linked events that should follow. As outlined 
by the World Health Organization (Wilson & Jungner, 1968), and more recently applied to 
the JJ system (Models for Change, 2007), screening is intended to be universal and aimed at 
identifying conditions not already known. Screening should also include procedures to 
ensure that youth who screen positive are systematically assessed further, and ultimately 
linked to care. Recent efforts to screen adolescents for substance use, depression, and 
anxiety during regular pediatrician visits provide a model for how universal screening might 
be accomplished in other settings (Sterling, Kline-Simon, Wibbelsman, Wong, & Weisner, 
2012; Wissow et al., 2013).
Effective screening should help efficiently and reliably identify potential BH problems in 
otherwise unidentified individuals (Lessler, 1972; New York State Department of Health, 
2015; Wilson & Jungner, 1968). Ideally, screening should (a) rely on a standardized 
validated instrument that is evidence-based, (b) be administered to all youth being 
processed, (c) rely on a relatively brief set of questions, (d) be suitable for administration by 
either clinical or non-clinical staff (although clinician review may be sometimes needed to 
resolve questions), and (e) generate clear decision rules regarding where and for what 
purpose a youth is referred on for additional clinical assessment. Universal screening is cost-
efficient because it allows more time consuming and costly assessment to be reserved for 
those youth more likely to have a SUD. This is important, as recent national survey data 
indicates that screening in community justice settings is not universal, and often contracted 
out to other agencies (Scott & Dennis, 2015; 2016).
Although recent efforts have prompted improvements in identification of BH concerns 
(Wachter, 2015), use of validated instruments remains low, with fewer than half of juvenile 
probation agencies in an earlier national survey using a standardized tool to screen or assess 
for SUDs (Young et al., 2007). In a recent nationally representative survey of juvenile 
probation agencies, only 53% reported conducting any screening for substance use or BH 
problems, 42% used standardized tools, and 38% used standardized tools on over half their 
youth. Only 11% conducted a more detailed clinical assessment (10.6% with standardized 
tools), and 6% used standardized assessment tools on 50% or more of youth (Scott & 
Dennis, 2015).
Assessment for BH problems is more comprehensive and multidimensional than screening 
and is designed to support diagnosis, placement, and treatment planning related to substance 
use and related problems (e.g., HIV risk, mental health disorders; Wasserman et al., 2003). 
A formal clinical assessment should (a) be conducted by trained clinical professionals, (b) 
rely on instruments or components that are evidence-based, and (c) address BH problem 
symptoms and diagnoses and related topics (e.g., treatment history, family history of BH 
problem, psychosocial history, barriers to care, amenability to treatment, functional 
impairment; ASAM, 2013; SAMHSA, 2015).
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In a large national survey of juvenile probation agencies (Scott & Dennis, 2015), 
approximately three-fourths reported referring youth on to BH agencies for assessment, 
rather than conducting the assessments themselves. This has implications for the placement 
of the “Referral” bar of the Cascade: depending on jurisdiction, it may reflect Screen/
Assess/Refer or Screen/Refer/Assess. Importantly, the same survey documented that BH 
assessments were more likely to rely on EB components when they were conducted in the 
BH agency itself than when they were conducted in the JJ setting. Keeping in mind the far 
greater cost of assessment activities, relative to screening activities, a public health approach 
to structuring relationships between screening and assessment activities allows for agency 
resources (budgetary, staffing) to be most clearly directed to clients with greatest need.
Our experience to date in JJ-TRIALS reveals that the timing and placement of assessment in 
the Cascade may vary across jurisdictions. In some systems, assessment is completed prior 
to treatment referral (e.g., court officers collect all relevant information prior to disposition 
hearing and referral may be made as part of a court order), while in other systems 
assessment is completed as part of a treatment referral (e.g., the BH provider does the 
assessment to determine appropriateness for treatment).
2.2.2. Identification of need—Identification of need is conceptualized as a discrete 
activity in the Cascade because screening and assessment results, as well as other 
information (e.g., current or past history of treatment, prior assessments), must be reviewed 
in order to inform case planning and subsequent referral (ASAM, 2013). Level of need can 
be conceptualized as a continuum, ranging from no use/no need to drug dependence, with 
classifications based on recommendation from assessment or screening results corroborated 
by another source (e.g., urinalysis results, parental report, treatment records). Level of need 
should then inform treatment referral—whether a referral should occur (i.e., substance use is 
above a designated threshold) and what level of care the youth should receive (e.g., 
outpatient versus residential level of care, recommended duration).
Traditional patient placement principles and criteria suggest that matching youth to services 
based on the specific needs of the youth will yield better clinical outcomes than providing 
generic programming (Childs & Sullivan, 2013; Taxman and Caudy, 2015). But when youth 
are placed in the wrong programming or not given sufficient treatment exposure, clinical 
outcomes are suboptimal. Treatment matching can help maximize the likelihood that youth 
receive treatment that addresses their specific needs, and reduces the complexity of service 
delivery by allowing the program to focus on clients with similar needs. Ideally, evidence-
based prevention or early intervention programs should be available for addressing the needs 
of youth who may not have problems of sufficient severity to warrant more intensive or 
formal treatment.
2.2.3. Referral—To be most effective, referral to substance use treatment should entail an 
active approach, whereby JJ staff work to link the family to services (Wasserman et al., 
2009). This active approach could include making a phone call to a specific agency with 
parents present, rather than providing families a list of possible providers and encouraging 
them to call. It could also involve help with scheduling appointments, providing reminders, 
assisting with transportation, and following up to confirm that the family showed up. More 
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generally, effective referral strategies may also include agreements with providers that 
specify the target population, the type and intensity of services offered, and the nature of 
pre-referral contact between juvenile probation staff and BH intake staff (for confirming 
eligibility, insurance coverage, hours of operation, and availability of a treatment slot). These 
strategies are especially important if the family is not supportive of treatment, which is often 
encountered in JJ settings.
2.2.4. Treatment initiation, engagement, and continuing care—We note that 
efforts to actively refer youth to appropriate services do not ensure that youth will receive 
those services. Consequently, it is critical to include in the Cascade the core stages of 
treatment process such as initiation, engagement, and continuing care. These measures were 
selected because they are recommended as policy indicators of service providers bolstered 
by empirical evidence that they are meaningful predictors of improved client level outcomes 
(Garnick et al., 2012; Hser et al., 2001; National Institute on Drug Abuse, 2014).
Treatment initiation refers to attending the first appointment with the provider. The 
“handoff” between JJ and treatment represents one of the most likely places for youth to 
“fall through the cracks,” even if services are provided internally by the JJ agency. The last 
two activities, engagement and continuing care, are contingent on initiation—one cannot 
engage or continue in services if the initial appointment has not occurred. Treatment 
engagement refers to the initial treatment contacts. The Office of National Coordinator 
performance criteria for health care reform suggests 2 or more sessions within 6 weeks 
(Office of National Coordinator, 2015). This is similar to the Washington Circle definition of 
treatment engagement (at least 2 treatment visits in the 30 days following treatment 
initiation), which has been found to predict reduced substance use for adolescents at six-
month follow-up (Garnick et al., 2012). Continuing care refers to a longer-term approach to 
rehabilitation that might include multiple treatment episodes or aftercare. We defined this as 
a minimum of 3 months in treatment, based on NIDA’s principles of adolescent SUD 
treatment (NIDA, 2014; see also Hser et al., 2001) which indicates improved outcomes for 
youth who engaged in treatment for at least three months and who participate in post-
treatment continuing care (e.g., drug use monitoring, follow-up visits, and support groups 
such as 12-step programs).
At each stage of the Cascade, timing, quantity, and quality of services are also important. 
The National Commission on Quality Assurance (NCQA; National Commission on Quality 
Assurance, 2013), National Quality Forum (NQF, 2012), and Office of National Coordinator 
(ONC) of Healthcare Reform (ONC, 2015), have all adopted standards that operationally 
define the initiation of and engagement in alcohol and other drug treatment. Unfortunately, 
only about one-third of providers met standards for timely initiation and fewer than 20% met 
engagement standards (NCQA, 2013). When compared against standards for screening and 
assessment, use of EBPs, availability of continuing care, and staff qualifications (e.g., 
American Society of Addiction Medicine, Commission on the Accreditation of 
Rehabilitation Facilities, Council on Accreditation, Joint Commission), publicly funded 
substance abuse treatment programs were recently found to meet only 6 of 14 indicators of 
quality treatment at least 80% of the time (Hunter, Griffin, Booth, Ramchand, & McCaffrey, 
2013). While application of the Cascade will not in itself improve use of EBPs, it serves to 
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highlight the importance of employing quality practices and measures across the Cascade if 
youth needs are to be fully met. Thus, a key element of the JJ-TRIALS staff training focuses 
on identifying and selecting appropriate EBPs for each stage of the Cascade. A full 
discussion of ways to increase EBP use is beyond the scope of the paper; however, several 
resources for identifying, selecting, and implementing EBPs exist (Manuel, Hagedorn, & 
Finney, 2011; OJJDP, 2016; SAMHSA, 2016).
2.3. Measuring steps within the Cascade
EBPs can be mapped onto each of the steps along the Cascade. The availability and use of 
these practices, as well as the successful handoffs or transitions between steps can be 
systematically measured, providing useful insight into how youth move through the 
Cascade, the quality of services available, and the degree to which services are utilized. 
Table 1 shows the definitions and formulas for measures at each step of the Cascade 
(developed according to standards set by organizations listed above). Determining the 
definition of the “denominator” is important for calculating performance rates at each stage. 
Using the lettered steps on the left, the performance rate for each step is shown as a formula 
on the right. The number of clinical assessments and the number in need would typically be 
a subset of those screened, because there may be structural reasons why a youth screened for 
substance use does not receive an assessment (e.g., the delinquency case is dismissed or 
otherwise closed, or the youth is already in treatment). Similarly, there may be valid reasons 
why a youth may not receive the appropriate next step in the Cascade; systems are not likely 
to ever serve 100% of those in need. Those unserved in a later Cascade steps (e.g., those 
referred but who do not enter treatment) represent “unmet needs” and are potential targets 
for further interventions or policy improvements.
In addition to the rate of retaining youth at each Cascade step, there is also value in 
characterizing “quality” dimensions. To focus only on the percentage of eligible youth 
receiving services at each step would not be meaningful if lower quality or poorly matched 
services are delivered or if there is a long delay in providing the needed service. Table 2 
summarizes suggested targets for the timing between each step and other quality indicators 
related to content or procedures. These are the benchmarks being applied in the JJ-TRIALS 
project, which were informed by those promulgated by NCQA, NQF, and other entities (see 
above).
3. Application of the Cascade in JJ-TRIALS
The primary JJ-TRIALS study uses a cluster randomized design to test the effectiveness of 
two implementation interventions (Core and Enhanced) for promoting improvements in 
substance use service delivery (Knight et al., 2016). The Cascade serves as a framework on 
which research questions, intervention protocols, and measurement strategies are based. 
First, a primary hypothesis states that the intervention will increase the percentage of youth 
“retained” at each stage of the Cascade. The Cascade framework specifies that (1) substance 
use services involve six distinct, yet interrelated activities; (2) gaps in receipt of these 
services can be conceptualized as “unmet need;” (3) because service areas are 
conceptualized as interconnected, improvement efforts should address outcomes (reducing 
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gaps) across all services in the continuum; and (4) change in an earlier Cascade bar will 
likely affect later Cascade bars (e.g., changes to screening will affect who is assessed; 
changes to referral will affect who initiates).
Second, the Cascade informs key elements of the JJ-TRIALS study’s intervention 
components. The Cascade provides a framework for developing content for staff training, 
reinforcing JJ staffs’ understanding of the importance of screening, assessment, appropriate 
referral, and treatment engagement. There are four key intervention components (for more 
detailed descriptions of these components, see Knight et al., 2016):
1. The JJ-TRIALS Behavioral Health Training materials focus on specific best 
practices associated with each Cascade step and on strategies for ensuring 
appropriate and efficient movement from one step to the next. The BH training 
focuses on substance abuse but also addresses mental health issues.
2. The agency-level Needs Assessment includes exploration (and detailed mapping) 
of the local JJ system showing the key points at which the various stages of the 
Cascade occur, as well as which agency and staff are responsible. The Needs 
Assessment activities solicit detail (from the perspectives of both JJ and BH 
staff) on linkage and service delivery points, quality indicators of the Cascade 
components (e.g., what screening and assessment practices are used, how are 
staff trained on those procedures), and how information is shared across 
agencies.
3. The Site Feedback Report (SFR) uses the Cascade graphic to organize and depict 
local results from three data sources: Needs Assessment, de-identified youth 
records, and JJ/BH agency survey responses. The SFR presents staff with the 
site’s youth service data, in terms of (a) retention (percentages of youth receiving 
a service or being “retained” in the Cascade across bars), (b) timing (number of 
days between various points in the Cascade), and (c) details regarding service 
delivery pertaining to each bar in the Cascade (including the specific tools used, 
strengths and challenges in the local site). The SFR concludes with a menu of 
possible goals that map onto the different steps of the Cascade. Data from the 
site are reported next to each potential goal, and this information is used by the 
local team to help select one goal to work toward over the course of the 12-
month experiment period. Ideally, the chosen goal corresponds to a step in the 
Cascade and requires some level of inter-agency collaboration.
4. Informed by the SFR, the first part of the Goal Achievement Training (GAT) 
establishes and trains local teams (including JJ and BH staff) to (a) identify gaps 
and build consensus across all agencies regarding what areas within the Cascade 
need attention, (b) narrow down potential goal options, (c) determine which 
goals are measurable, and (d) select a Cascade-related goal. The second GAT 
session emphasizes the importance and utility of Data Driven Decision Making 
(DDDM; Marsh, Pane, & Hamilton, 2006) and instructs teams on use of Plan-
Do-Study Act rapid cycle testing procedures (McCarty et al., 2007; Moule, 
Evans, & Pollard, 2013; Taylor et al., 2014) for implementing and testing the 
selected goal.
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Third, the Cascade informs measurement procedures and instrument development. Data 
related to the various bars in the Cascade are used to measure and observe progress toward 
the selected goal. Cascade data are generated from a combination of electronic and paper 
case records. In addition to providing Cascade data in the initial SFR, JJ-TRIALS Research 
Centers also generate quarterly reports on retention within the cascade (based on cohorts of 
youth entering the JJ system), and a final SFR summarizing changes since the baseline 
(including retention, timing, and detail within the Cascade).
In each of the intervention components described above, the Cascade is used as a framework 
for collecting, synthesizing, and/or interpreting information as it relates to youths’ receipt of 
SU services. The critical elements of the Cascade are defined and described in training. The 
degree to which Cascade elements are being implemented within the JJ system is assessed 
through the Needs Assessment and depicted visually (and presented to leadership) in the 
SFR. Strategies for how to continue to assess movement through the Cascade and address 
deficiencies in services is the subject of GAT training. In addition to these components and 
quarterly Cascade data reports, the Needs Assessment and SFR are repeated at the end of the 
project experiment to provide site leadership with feedback on change over time. 
Interagency workgroups are encouraged to examine their own data to monitor changes in 
their Cascade-related goal, and consider (a) how their efforts might be impacting other bars 
in the Cascade and (b) whether they should turn attention to a new goal (perhaps in another 
stage of the Cascade).
3.1. Challenges encountered
Over the approximately 18 months that the Cascade has been used in JJ-TRIALS, the 
primary challenge to its utilization has been related to data collection, especially for later 
Cascade steps (past screening and assessment). In general, JJ management information 
systems focus on case processing data (to ensure appropriate legal proceedings). JJ agencies 
and their probation officers are not routinely asked to report on BH services, and generally 
do not have incentives to capture service delivery information in JJ databases. The JJ 
database systems in the 35 study sites (and generally across the U.S.) typically capture the 
“front end” stages (i.e., intake into JJ and screening), but rarely capture (in electronic form) 
complete information from the BH services provider on treatment referral, initiation, or 
engagement in treatment.1 This information is often recorded in the provider’s electronic 
records or in paper/electronic case notes, but both cannot readily be linked to JJ data 
systems. Information may be recorded in JJ paper case files or electronic case notes, but data 
extraction of text files is difficult, time consuming, and costly. Further, case files may be 
difficult to find or located in multiple offices. Staff turnover may result in loss of 
information, especially if documentation has been inconsistent. It can be difficult to 
determine if a lack of recorded treatment information means that the service did not occur, 
or did occur but was not recorded in a retrievable form. The adoption of newer electronic 
record systems in some JJ-TRIALS sites aimed at capturing assessment results, treatment 
1Data from the JJ-TRIALS national survey of juvenile justice agencies indicate that 68% have an electronic records system that can 
track substance abuse or mental health screening or clinical assessment data (Scott & Dennis, 2015).
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referrals, and treatment service dates has helped address many of these data collection 
challenges.
Another challenge is that definitions of what constitute “screening,” “assessment,” 
“substance use problem,” “treatment need,” and “appropriate treatment,” vary across JJ 
jurisdictions. When a state mandates the use of a particular screening instrument, the ways 
in which the instrument is employed (when administered, to whom, how results are used, 
whether results are used) also may differ across jurisdictions. Many juvenile courts and 
probation agencies use drug testing to screen incoming youth and to determine treatment 
need; such information may be useful for determining recent drug use, but is insufficient as 
an indicator of treatment need. If a screening instrument is used, it may not be evidence-
based, or universally administered. Juvenile court intake and probation staff conduct 
assessments of criminogenic needs and recidivism risk in order to make case disposition and 
services recommendations. They typically do not conduct clinical assessments for diagnostic 
purposes and determination of appropriate level of care, but rely on treatment providers for 
this function. If JJ staff members are conducting clinical assessments, they often are not 
using an evidence-based or standardized tool (Young et al., 2007). The Cascade framework 
does not depict whether the youth are placed in evidence-based treatments, integrated SUD 
and mental health care, or other key features of treatment. However, the Cascade is readily 
adaptable to add or modify bars that include delivery of evidence-based or integrated 
services.
Finally, there are limitations that could complicate dissemination and scaling up of the 
Cascade framework beyond JJ-TRIALS. First, the Cascade is an ideal representation of the 
sequence of events that should occur in the process of linking young offenders with 
appropriate services. While our conceptualization focuses on a single primary path, the 
reality can be more complex. Youth who enter treatment may drop out and need to be 
referred again. Youth who are not assessed or referred may choose to go to treatment on 
their own (or based on referral from a parent or lawyer), or they may already be in treatment 
at the time of their offense and referral to JJ. Court proceedings and legal counsel can also 
impact the timing and receipt of services, further complicating the process. For example, 
attorneys might advise against clinical assessment (especially during the early stages of case 
processing) or judges can order treatment independent of screening or assessment results. 
Although we have collected data on these other paths for future investigation, exploring all 
possible paths is beyond the scope of this paper. Second, it is likely that agencies and 
systems wishing to use the Cascade outside of a research setting would need to receive some 
training and technical assistance in order to maximize its utility.
3.2. Positive initial outcomes resulting from Cascade use
During initial interactions with JJ-TRIALS study sites and discussions of data issues related 
to the Cascade, several potential solutions to the challenges of populating the Cascade charts 
have emerged. First, using the Cascade as a conceptual foundation for the Needs 
Assessments and SFRs has helped JJ and BH leadership grasp the utility of collecting, 
analyzing, and using this information, as well as the importance of accurate recordkeeping. 
We are working with site leadership and data systems managers to develop processes and 
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procedures for capturing the data more efficiently and accurately. For example, in several 
jurisdictions we are collaborating with Information Technology staff to add data fields 
related to the Cascade to the electronic data system. Another clear benefit is that in several 
sites, agency leadership is increasing efforts to train line staff on documenting treatment 
service-related activities accurately and in a timely manner. Finally, it will become important 
to set up systems for regularly monitoring Cascade data and providing feedback to site staff. 
Quarterly Cascade reports will fulfill this function, while also providing feedback to the sites 
on how well they are meeting the goals that they have selected for improving selected 
aspects of the Cascade process.
4. Implications for Substance Use Treatment System
4.1. Benefits from an organizational perspective
A visual representation that captures and summarizes key elements needed to identify SUDs 
and link individuals to appropriate services has several potential benefits for JJ and BH 
organizations: facilitating increased awareness of best practices for substance use services, 
improving interagency collaboration and communication, and providing a platform for 
monitoring, evaluating, and improving performance. Further the Cascade can focus attention 
on the nature of the services available given the screening and assessment information.
4.1.1. Facilitating increased awareness of best practices for substance use—
The Cascade can be used as a training tool for both JJ and SUD or BH treatment staff. It 
operationalizes the steps, sequences, and quality indicators needed to respond effectively to 
youth substance use problems, as well as how and what interagency collaborations are 
needed to achieve significant treatment gains. Training administrative staff on the Cascade 
may help to facilitate JJ and treatment systems’ commitment to providing EB treatment 
services to delinquent youth in the community by increasing willingness to focus resources 
and staff time on improving performance along the Cascade. Training line staff (e.g., 
probation officers, case managers) on Cascade steps may also benefit youth by encouraging 
staff to (1) embrace the use of EBPs in core areas of screening, assessment, (active) referral, 
and treatment programming, (2) monitor and where feasible reduce the time between 
Cascade events, (3) support interagency collaboration and communication (especially when 
sharing information regarding assessment or treatment attendance); and (4) support 
improvements in information systems infrastructure to facilitate collection and accuracy of 
Cascade data.
4.1.2. Improving interagency collaboration and communication—The Cascade 
can also be used to facilitate coordination, collaboration, and information sharing between JJ 
agencies and providers. Using a graphic tool such as the Cascade can provide a common 
taxonomy, help to articulate shared goals, identify key cross-systems transition points and 
stages at which coordination and data sharing are needed, and illustrate areas in need of 
improvement (Dansereau & Simpson, 2009). It may also be helpful in facilitating 
conversations and ultimately foster the development of a common mission across the JJ and 
BH systems.
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Challenges encountered in interagency collaboration and information sharing should result 
in modifications/improvements in procedures, practices and data collection. One expected 
result is improved understanding between JJ and treatment agencies of one another’s roles 
and responsibilities in substance use service delivery. Another is potentially better 
integration of services provided by multiple agencies, as leadership and policymakers work 
together to apply the Cascade to their specific populations and service networks. Together, 
they can explore problem sources, brainstorm potential solutions, and identify where 
additional training and interagency collaboration are needed to more effectively respond to 
youth treatment needs.
4.1.3. Platform for monitoring, evaluating, and improving performance—Using 
the Cascade as a framework for monitoring system performance has the potential to benefit 
the local JJ and BH systems because performance-oriented organizations tend to adopt more 
EBPs (Friedmann, Taxman, & Henderson, 2007; Taxman & Belenko, 2012). Here, 
performance refers to the establishment of set goals, the ability to assess how well the 
system is doing in obtaining these set goals, and the ability to coordinate data across 
systems. The focus on performance at each stage of the Cascade, then, can identify gaps in 
services and procedures as well as the ability to assess how individual agencies are 
facilitating youth access to care. It removes the potential discomfort of focusing on only one 
agency when gaps in services are observed, rather than acknowledging systems and 
interagency issues that are common in multisystem settings (Taxman & Belenko, 2012).
The Cascade framework is not meant to depict a static process, but one that is adaptable and 
can evolve over time. Accordingly, Cascade data could be used to understand how the 
substance use service delivery system needs to be calibrated, and modified to accommodate 
changes in the funding and regulatory environment, emergence of new drugs (e.g., synthetic 
or designer drugs) and new patterns of use, and development of new assessment, treatment, 
and data monitoring technologies. Service delivery systems need to be able to respond 
effectively to the changing adolescent substance use and treatment landscape. At the same 
time, the Cascade provides a sequential, patterned service delivery model which has the 
potential to inform effective responses to these issues.
Consequently, the Cascade can be used as a mechanism for data-driven decision making. 
Key stakeholders representing various agencies can collect data and depict findings using the 
Cascade graphic. The information can then be used to inform decisions that will help 
improve, refine, or reform a range of outcomes and practices (Marsh et al., 2006). 
Populating the graphic with actual data makes the Cascade relevant to all stakeholders and 
enables individuals from multiple agencies opportunities to interpret data according to their 
own agency’s perspective, further facilitating the exchange of information and ideas. 
Strengths in the way youth are served can be acknowledged, and gaps can be identified and 
addressed. Reviewing the data at regular intervals provides accountability and can be used to 
document improvement and/or identify additional areas in need of attention. For example, 
monitoring performance along the Cascade can inform areas where receipt of services is less 
than ideal (e.g., 40% of youth are “in need” of treatment, but only half of those in need are 
referred for services; lengthy delays in getting screened or assessed). The Cascade 
framework can also be used by agencies to determine whether subgroups of youth (e.g., 
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females, youth with comorbid mental health disorders) are progressing through the steps at 
different rates than other youths (and whether targeted interventions are needed), or whether 
sizeable numbers exhibit lower levels of substance use and might benefit from prevention or 
early intervention. Programming and placement adaptations such as these can potentially 
impact successful movement through the Cascade. As agencies use the Cascade to study 
their own systems, they ideally would not only modify service provision but would also 
adapt the visual Cascade to reflect those modifications (e.g., depicting decision points or 
thresholds for early-intervention versus outpatient treatment referral decisions).
4.2. Benefits to youth and their families
The Cascade provides a comprehensive picture of the substance use services continuum--
from identification, to intervention, to follow-up care. Seen in this way, it is more likely that 
informed, integrated service delivery systems can be developed to better serve justice 
involved youth with substance use issues, and their families. The fuller depiction of the steps 
in the Cascade can be used to educate youth and their families regarding what they should 
expect in this process. JJ clients and their parents/families are often ill-informed about the 
substance use service continuum (Burney-Nissen et al., 2006; Wasserman et al., 2009). 
Knowledge about this process can help them more clearly understand important points of 
contact and transition, and empower them in the key role they play as a catalyst and 
supporter of their child’s recovery.
4.3. Implications for organizational change and implementation science
The Cascade provides a visual tool that can be useful for JJ and treatment stakeholders, 
administrators, and staffs seeking to increase access to services for SUD-involved youth. 
Visualizing and understanding how the system operates can be useful to begin to build 
processes that allow for more collaborative or integrated services. Lehman et al. (2009) 
found that systems that were collaborative and integrative were more likely to implement 
EBPs. The Cascade can also be a useful training tool, for both JJ and BH staff, on the need 
for a common mission and goals that emphasize the importance of SU and related treatment 
services for delinquent youth. The visualization of the Cascade provides the opportunity to 
view the outcomes of their intake and referral processes in such a manner that it can be used 
to develop refinements and measure outcomes. This helps move away from the perception 
that it is the “unmotivated” youth that does not engage in services to a perspective that the 
system also has barriers to services access. Also, it allows for more attention to helping staff 
understand concepts underscoring EBPs which should increase their willingness to engage 
in implementing them (Taxman et al., 2014). Recent studies have found that in addition to 
training, staff need coaching that reinforces the use of EBPs but also provides guidance on 
how to apply the EBPs in actual situations to improve youth outcomes (Taxman et al., 2014; 
Young, Farrell, & Taxman, 2013).
Finally, existing implementation science models, such as the EPIS model (Aarons et al., 
2011) or Consolidated Framework for Implementation Research (CFIR; Damschroder et al., 
2009) could be used to inform research on various aspects of the Cascade. These models 
emphasize the importance of key domains that can influence program implementation, such 
as (1) intervention characteristics; (2) outer setting or the stakeholders affecting the 
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environment or social context; the (3) inner setting including structural factors, culture, 
climate and readiness for change; (4) individuals involved and their knowledge, 
organizational commitment and motivation; and (5) the implementation process or change 
strategy. It would be useful to analyze the Cascade model by these domains to get a more 
refined sense of the implementation issues at each phase. This could help build a knowledge 
base about the factors that affect cross-system efforts related to adoption and implementation 
of improved treatment services for youth.
5. Discussion
Recent decades have seen an increased use of screening and assessment procedures in 
community JJ settings, including the use of evidence-based instruments in many 
jurisdictions, in making treatment recommendations (Models for Change, 2007). At the 
same time, although ongoing referrals to treatment service providers are common in the JJ 
system, treatment program linkage, engagement and follow-up care, all critical elements in 
reducing involvement in substance use, remain underdeveloped activities in many 
jurisdictions. Although a somewhat simplistic representation of what can be a complex 
process, the Cascade highlights critical points of contact and transition in the treatment 
continuum to inform the identification of unmet needs by JJ agencies and treatment 
providers. The Cascade framework seeks to guide systems to use EBPs, data-driven decision 
making, and audit and feedback. But the ultimate impact on youth outcomes also depends on 
the implementation or expansion of EBPs, and JJ and BH staff training in the use of the 
Cascade needs to emphasize the importance of service quality and use of best practices, 
guided by existing EBP guidelines and repositories (NIDA, 2014; OJJDP, 2016; SAMHSA, 
2016).
The various steps in the Cascade correspond to measurable activities that should occur in a 
logical sequence, and that may involve multiple agencies and “handoffs” across service 
systems. A number of key policy and service delivery questions arise from the Cascade: 
What proportion of those at JJ system intake is screened for SU and related service needs? 
What proportion of those with identified need is referred on to treatment services? What 
proportion of those who initiate treatment is retained long enough to benefit? Are shorter 
periods between steps associated with higher retention at the next step? As such, this model 
and the quantitative tracking that follows from it are broadly applicable for use in any 
healthcare or social services delivery system, where there is a defined sequence of 
measurable events that need to occur across systems for optimal delivery of services 
appropriate to the needs of the clients. Although we developed the Cascade as a framework 
for studying and improving substance use treatment services for youth under community JJ 
supervision, the model is readily adaptable to other systems and processes such as the adult 
criminal justice system, mental health services, health care screening and treatment, STI 
testing and treatment, child welfare, education, and other service systems. The Cascade is an 
example of how articulating an overarching framework can be used to harmonize 
measurement across diverse sites and systems, and inform the development of new measures 
related to cross-systems coordination and systems integration.
Belenko et al. Page 18
J Subst Abuse Treat. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
5.1. Limitations
We are aware that the Cascade model simplifies what can be a complex process, but in 
developing the model (in collaboration with our JJ and BH agency project partners), we 
determined that a graphically clear, straightforward depiction of the process was important 
to enable agency staff, including line staff as well as supervisors and administrators, to 
clearly see the sequential nature of the process and key transition points. Indeed, as we have 
implemented the Cascade across 35 JJ systems over the past 18 months, we have found that 
providers and JJ agency staff understand what it represents, and have found it quite useful in 
guiding the use of data to make meaningful changes in their screening, assessment, referral, 
and treatment process for youth under community supervision.
As discussed earlier, we also recognize that because delinquent youth often have comorbid 
mental health and other problems in addition to SUDs, assessing for multiple issues and 
identifying and linking these youth to appropriate treatment services can be a complicated 
and difficult undertaking. Although the Cascade is a helpful starting point for summarizing 
and studying the process of SU treatment service delivery, it cannot necessarily account for 
all of the complexities in providing optimal and timely treatment of comorbid conditions.
Given the limitations of JJ management information systems and the current difficulties 
many agencies have in linking JJ and services data, part of the JJ-TRIALS study protocol 
included an active researcher role in helping sites initially use the Cascade and collect the 
relevant data. As noted earlier, several sites have made permanent changes in their 
information systems to allow for continuing collection and reporting of Cascade data. In half 
of the sites, JJ-TRIALS facilitators provide active support to assist organizations in using 
and adapting the Cascade-based tools as they pursue different goals. Although sustainability 
is a key focus of JJ-TRIALS and several tools were developed to facilitate use of the 
Cascade by sites, in non-research settings it may be difficult for agencies to obtain the full 
benefits of using the Cascade framework to model and study their SU treatment delivery 
system. At the end of the study period, NIDA plans to post JJ-TRIALS materials to the 
NIDA website to allow other jurisdictions to use and adapt them as needed.
Finally, although the Cascade measures employ some qualitative dimensions related to the 
timing and quantity of services, it does not directly address treatment quality. However, the 
JJ-TRIALS trainings emphasize and provide substantive material on EBPs in prevention, 
screening, assessment, treatment, and interagency collaboration. In future development of 
the Cascade, we hope to enhance the framework to account for and measure use of EBPs 
and additional measures of service quality.
5.2. Conclusions
We developed the Cascade framework with the goal of serving both research and practice 
needs. A key goal of JJ-TRIALS has been to understand how the Cascade can facilitate the 
use of process improvement goals and measures to improve access to appropriate SU 
treatment services to young offenders in the community. Qualitative interviews and other 
data collection activities from the study will provide insights regarding how well these tools 
worked in different field settings. In turn, these lessons learned could lead to future studies 
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aimed at enhancing the sustainability and dissemination potential of the Cascade for wider 
use within JJ settings.
As the use of the Cascade continues in the JJ-TRIALS research cooperative, new insights are 
expected in terms of its utility for guiding JJ and BH agencies in identifying unmet 
substance use service needs among delinquent youth under community supervision, and 
developing and testing organizational and policy changes to reduce those unmet needs. 
Moreover, the data collected on the multiple steps in the Cascade will be used to test key 
hypotheses about the impact of different implementation interventions on the ability to 
reduce unmet substance use service needs across the JJ-TRIALS sites. It is also likely that 
other challenges may arise as we continue to implement the Cascade and agencies gain more 
experience in using it for process improvement efforts.
As previously highlighted, the current version of the Cascade focuses on substance abuse 
service delivery system. Future efforts need to expand the attention to linking assessment 
needs to various treatment types as part of an overall strategy to provide integrated care 
models. This is especially important given the multidimensional needs of delinquent youth 
that frequently require both treatment for substance abuse and mental health services. We are 
currently testing the Cascade framework for SUD services. But meeting the various BH 
needs of delinquent youth is a challenge that JJ agencies need to address. Lessons from the 
JJ-TRIALS should be informative as to how to build organizational links to provide more 
comprehensive services for youth.
The ultimate goal of a collaborative and coordinated JJ-BH “meta-system” is to maximize 
the proportion of substance-involved youth who are identified, referred, initiated, and 
retained in substance use treatment for a sufficient period of time to achieve clinically 
meaningful effects. Full engagement in appropriate services will provide both public health 
and public safety benefits, given the connection between substance use and delinquency 
(Belenko & Logan, 2003; Evans-Cuellar et al., 2006; Hoeve et al., 2013; Wasserman et al., 
2010; Zhang, 2004). Even in the early phases of JJ-TRIALS, the Cascade has proven to be a 
valuable heuristic tool for conceptualizing a complex multi-system and multi-site service 
delivery system and informing both researchers and practitioners about the processes for 
providing substance use services to youth in the JJ system and measuring their impacts and 
interconnections. It is hoped that these experiences will be empowering and reinforce 
continued use of the Cascade framework and it associated tools and procedures after the JJ-
TRIALS study ends.
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HIGHLIGHTS
• Adolescent offenders have significant need for sub stance abuse treatment
• Agencies need systematic guidance for improving identification and referral 
of youth to services
• A Juvenile Justice Behavioral Health Services Cascade is proposed
• The Cascade helps identify unmet needs and areas for organizational 
intervention
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Figure 1. 
Juvenile Justice Behavioral Health Services Cascade: Hypothetical Illustration of Unmet 
Needs for Youth under Community Juvenile Justice Supervision
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Table 1
Behavioral Health Services Cascade Definitions
Step Operational Definition Rate
a. JJ Referrals Total number of referrals to juvenile justice in time period with a
disposition starts date, less any youth already in treatment at that time.
--
b. Screened Subset of JJ referrals (a) with a screening date. b/a
c. Clinical
Assessment
Subset of JJ referrals (a) with a full clinical assessment (includes if
follow-up to screening or other clinical assessment).
c/a
d. Need
Identified
Subset of JJ referrals (a) with a need for substance use treatment
based on screener, urinalysis, clinical assessment, or other sources
of information.
d/a
e. JJ Referrals
to Treatment
Subset of those in need (d), referred by the juvenile justice system
to substance use treatment.
e/d
f. Initiated
Treatment
Subset of those referred to treatment (e) who have treatment start
date.
f/e
g. Engaged In
Treatment
Subset of those who initiate treatment (f) who stay in treatment for
at least 6 weeks (based on treatment discharge minus treatment
start date).
g/f
h. Continuing
Care
Subset of those engaged in treatment (g) that are still getting
treatment after 90 days (whether via retention, transfer or booster).
h/g
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Table 2
Service Cascade Timing and Quality Measures
Service
Cascade Step Timing
Quality
Indicators
a. Referred NA • NA
b. Screened Days between intake
and screen
(target: 30 days)
• Use of a psychometrically sound screening instrument
• Use of 2+ sources of corroborating evidence
• Training and quality assurance provided to staff
• Screening results used to inform referral to full clinical assessment and/or treatment
c. Clinical
Assessment
Days between intake
and assessment
(target: 30 days)
• Use of a psychometrically sound clinical instrument
• Use of 2+ sources of corroborating evidence
• Training and quality assurance provided to staff on administration and interpretation
• Assessment results used to inform placement plans
• Qualifications of staff doing assessment
d. Need
Identified
Days between intake
and determination of
need (target: 14 days
from last of b/c)
• Determined by results of a psychometrically sound screening or assessment 
instrument
• Documentation of need in record/service plan
• Communication of needs across system (e.g., judge, PO)
e. JJ Referred to
Treatment
Days between
determined need and
referral
(target: 14 days)
• “Quality” of services (i.e., licensed/ accredited/ certified)
• Match between client needs and service intensity
• Program contact provided
• Active referral (e.g., Phone call made; transportation provided)
f. Initiated
Treatment
Days between
referral and first
session
(target: 14 days)
• Use of evidenced-based treatment approach
• Sharing information (e.g., documentation of first session confirmed by service 
agency)
g. Engaged In
Treatment
Measure based on 6
or more weeks in
treatment
• % of Youth receiving 3+ sessions within first 6 weeks
• Treatment completion/ discharge status
• % youth receiving treatment services from JJ agency
• Qualifications of staff providing treatment services
• Sharing information (e.g., documentation of multiple sessions confirmed by service 
agency)
h. Continuing
Care
Measure based on 90
or more days in any
kind of treatment
• Retention/dosage within each episode
• Service intensity across episodes
• Sharing information (e.g., documentation of attendance confirmed by service agency)
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